Literature DB >> 24751895

Skin antisepsis in the neonate: what should we use?

Vennila Ponnusamy1, Vidheya Venkatesh, Paul Clarke.   

Abstract

PURPOSE OF REVIEW: Neonates in intensive care are more susceptible to sepsis. Infection is commonly acquired via the transcutaneous portal. It is necessary to identify the most effective yet safest topical antiseptics for use in neonates to reduce nosocomial sepsis. RECENT
FINDINGS: Recent national surveys indicate that a wide range of topical antiseptic preparations are used in the neonatal nursery. There are very few comparative studies in neonates and no robust evidence in favour of any particular antiseptic. There are significant safety and potential toxicity issues for neonates with all the commonly used antiseptics, particularly in very small immature babies. There are no convincing roles for routine application of emollient creams on the skin, topical antiseptics on the umbilical stump, or maternal vaginal washes with chlorhexidine for the prevention of neonatal infection.
SUMMARY: Large multicentre trials are needed to determine the optimal antiseptic to use for neonates undergoing intensive care, especially for extremely preterm infants.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24751895     DOI: 10.1097/QCO.0000000000000064

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  6 in total

Review 1.  Late-onset neonatal sepsis: recent developments.

Authors:  Ying Dong; Christian P Speer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2014-11-25       Impact factor: 5.747

2.  The impact of chlorhexidine gluconate bathing on skin bacterial burden of neonates admitted to the Neonatal Intensive Care Unit.

Authors:  Julia Johnson; Nuntra Suwantarat; Elizabeth Colantuoni; Tracy L Ross; Susan W Aucott; Karen C Carroll; Aaron M Milstone
Journal:  J Perinatol       Date:  2018-09-20       Impact factor: 2.521

3.  Safety and efficacy of 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheter insertion in preterm neonates: the ARCTIC randomised-controlled feasibility trial protocol.

Authors:  Paul Clarke; Jean V Craig; John Wain; Catherine Tremlett; Louise Linsell; Ursula Bowler; Ed Juszczak; Paul T Heath
Journal:  BMJ Open       Date:  2019-02-19       Impact factor: 2.692

4.  Comparison of Skin Antiseptic Agents and the Role of 0.01% Hypochlorous Acid.

Authors:  Ann Q Tran; Nicole Topilow; Andrew Rong; Patrice J Persad; Michael C Lee; James H Lee; Apostolos G Anagnostopoulos; Wendy W Lee
Journal:  Aesthet Surg J       Date:  2021-09-14       Impact factor: 4.485

5.  Chlorhexidine gluconate usage is associated with antiseptic tolerance in staphylococci from the neonatal intensive care unit.

Authors:  Dheeraj K Sethi; Heather Felgate; Maria Diaz; Kirstin Faust; Cemsid Kiy; Paul Clarke; Christoph Härtel; Jan Rupp; Mark A Webber
Journal:  JAC Antimicrob Resist       Date:  2021-11-17

6.  Variation in infection prevention practices for peripherally inserted central venous catheters: A survey of neonatal units in England and Wales.

Authors:  Caroline Fraser; Katie Harron; Laura Dalton; Ruth Gilbert; Sam J Oddie
Journal:  PLoS One       Date:  2018-11-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.